Article

Status and progress of Icotinib in treatment of EGFR-mutant non-small cell lung carcinoma

2022-06-22

Abstract excerpt

Lung cancer has a high incidence and mortality worldwide. Among them, non-small cell lung cancer (NSCLC) accounts for the majority. In terms of treatment, targeted therapy is a more effective option for NSCLC patients with genetic mutations when compared with chemotherapy. Currently, there are a number of targeted drugs targeting different mutations in NSCLC on the market, among which, icotinib (Conmona®) is an or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 36d953b1-8d1c-5b76-9e4f-1fa682210cdf
DOI: 10.21203/rs.3.rs-1765725/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Status and progress of Icotinib in treatment of EGFR-mutant non-small cell lung carcinomaDOI 10.21203/rs.3.rs-1765725/v1Read

[Expert consensus on icotinib as adjuvant therapy for non-small cell lung cancer].Semantic proximity Read

[Clinical research and drug review of epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer].Semantic proximity Read

Effective treatment with icotinib in advanced lung adenocarcinoma harboring rare EGFR mutation G719A/L833V: A case report.Semantic proximity Read

[China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2016 version)].Semantic proximity Read

The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review).Semantic proximity Read

[Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified].Semantic proximity Read

Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies.Semantic proximity Read

Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer.Semantic proximity Read

Efficacy and safety of icotinib in the treatment of advanced EGFR mutation-positive nonsmall cell lung cancer: A meta-analysis of randomized controlled trials.Semantic proximity Read

The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.Semantic proximity Read

Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and PerspectiveSemantic proximity Read

Molecular target therapeutics of EGF-TKI and downstream signaling pathways in non-small cell lung cancers.Semantic proximity Read